Firebrick Pharma Limited (FRE.AX) has a profit margin of -916.71%, below the sector sector average of 13.4%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Firebrick Pharma Limited (FRE.AX) currently reports a profit margin of -916.71% as of June 2026. That compares with -289.99% in the prior-year period — down 216.1% year over year. That is below the sector sector average of 13.4%. Use the charts on this page to explore Firebrick Pharma Limited's profit margin history and peer comparisons.
Firebrick Pharma Limited's profit margin decreased from -289.99% to -916.71% — a 216.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Firebrick Pharma Limited's profit margin of -916.71% is lower than the its sector sector average of 13.4%. That is roughly 6939.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Firebrick Pharma Limited's current -916.71% should be judged against industry norms (sector average: 13.4%) and against FRE.AX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -916.71%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.4%. From there, open related valuation or income-statement pages for Firebrick Pharma Limited, and consider following FRE.AX for alerts when major investors trade the stock.